Nanoparticle diffusion in respiratory mucus from humans without lung disease

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3439-3446

  Schuster, Benjamin S ^a   Suk, Jung Soo ^a,d   Woodworth, Graeme F ^a,b,c   Hanes, Justin ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c Johns Hopkins University   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Inhaled nanoparticles; Mucus penetrating particles; Multiple particle tracking; Respiratory mucus; Rheology

Indexed keywords

AIRWAY EPITHELIUM; BARRIER PROPERTIES; COMORBIDITIES; DESIGN CRITERIA; HEALTH IMPLICATIONS; INHALED PARTICLES; LOW MOLECULAR WEIGHT POLYETHYLENES; MACROSCOPIC LEVELS; MUCUS-PENETRATING PARTICLES; MULTIPLE PARTICLE TRACKING; PARTICLE SIZE AND SURFACES; POLYMERIC NANOPARTICLES; RESPIRATORY MUCUS; SURGICAL PATIENTS; VISCOELASTIC SOLIDS; VISCOUS LIQUIDS;

NANOPARTICLES; POLYETHYLENE GLYCOLS; PULMONARY DISEASES; RHEOLOGY; SURFACE CHEMISTRY;

BODY FLUIDS;

MACROGOL; NANOPARTICLE; POLYMER;

ARTICLE; DIFFUSION; DRUG DESIGN; DRUG PENETRATION; FLOW KINETICS; HUMAN; MATERIAL COATING; PARTICLE SIZE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; SURFACE PROPERTY; TRACHEA MUCUS; TRANSPORT KINETICS; VISCOSITY;

BIOLOGICAL TRANSPORT; DIFFUSION; HUMANS; LUNG; LUNG DISEASES; MICROSCOPY, ELECTRON, SCANNING; MUCUS; NANOPARTICLES; RHEOLOGY; TIME FACTORS; VISCOSITY;

EID: 84874239794     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.064     Document Type: Article

References (45)

1. Button B., Cai L.H., Ehre C., Kesimer M., Hill D.B., Sheehan J.K., et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 2012, 337:937-941.
2. Fahy J.V., Dickey B.F. Airway mucus function and dysfunction. N Engl J Med 2010, 363:2233-2247.
3. Sanders N.N., De Smedt S.C., Demeester J. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J Pharm Sci 2000, 89:835-849.
4. Tarran R., Grubb B.R., Gatzy J.T., Davis C.W., Boucher R.C. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol 2001, 118:223-236.
5. Lai S.K., Wang Y.Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009, 61:158-171.
6. Lai S.K., O'Hanlon D.E., Harrold S., Man S.T., Wang Y.Y., Cone R., et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A 2007, 104:1482-1487.
7. Suk J.S., Lai S.K., Wang Y.Y., Ensign L.M., Zeitlin P.L., Boyle M.P., et al. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials 2009, 30:2591-2597.
8. Sanders N.N., De Smedt S.C., Van Rompaey E., Simoens P., De Baets F., Demeester J. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am J Respir Crit Care Med 2000, 162:1905-1911.
9. Lai S.K., Suk J.S., Pace A., Wang Y.Y., Yang M., Mert O., et al. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials 2011, 32:6285-6290.
10. Cone R.A. Barrier properties of mucus. Adv Drug Deliv Rev 2009, 61:75-85.
11. Valentine M.T., Perlman Z.E., Gardel M.L., Shin J.H., Matsudaira P., Mitchison T.J., et al. Colloid surface chemistry critically affects multiple particle tracking measurements of biomaterials. Biophys J 2004, 86:4004-4014.
12. Lai S.K., Wang Y.Y., Hida K., Cone R., Hanes J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A 2010, 107:598-603.
13. Rubin B.K., Ramirez O., Zayas J.G., Finegan B., King M. Collection and analysis of respiratory mucus from subjects without lung disease. Am Rev Respir Dis 1990, 141:1040-1043.
14. Fahy J.V., Wong H., Liu J., Boushey H.A. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med 1995, 152:53-58.
15. Rubin B.K., Finegan B., Ramirez O., King M. General anesthesia does not alter the viscoelastic or transport properties of human respiratory mucus. Chest 1990, 98:101-104.
16. Nielsen H., Hvidt S., Sheils C.A., Janmey P.A. Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients. Biophys Chem 2004, 112:193-200.
17. Janmey P.A., Georges P.C., Hvidt S. Basic rheology for biologists. Methods Cell Biol 2007, 83:3-27.
18. Crowther R.S., Wetmore R.F. Fluorometric assay of O-linked glycoproteins by reaction with 2-cyanoacetamide. Anal Biochem 1987, 163:170-174.
19. Saltzman W.M., Radomsky M.L., Whaley K.J., Cone R.A. Antibody diffusion in human cervical mucus. Biophys J 1994, 66:508-515.
20. Nance E.A., Woodworth G.F., Sailor K.A., Shih T.Y., Xu Q., Swaminathan G., et al. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med 2012, 4:149ra19.
21. Suh J., Dawson M., Hanes J. Real-time multiple-particle tracking: applications to drug and gene delivery. Adv Drug Deliv Rev 2005, 57:63-78.
22. Saxton M.J., Jacobson K. Single-particle tracking: applications to membrane dynamics. Annu Rev Biophys Biomol Struct 1997, 26:373-399.
23. Mason T.G., Weitz D.A. Optical measurements of frequency-dependent linear viscoelastic moduli of complex fluids. Phys Rev Lett 1995, 74:1250-1253.
24. Mason T.G., Ganesan K., van Zanten J.H., Wirtz D., Kuo S.C. Particle tracking microrheology of complex fluids. Phys Rev Lett 1997, 79:3282-3285.
25. Macosko C.W. Rheology: principles, measurements, and applications 1994, VCH, New York.
26. App E.M., Kieselmann R., Reinhardt D., Lindemann H., Dasgupta B., King M., et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest 1998, 114:171-177.
27. Innes A.L., Carrington S.D., Thornton D.J., Kirkham S., Rousseau K., Dougherty R.H., et al. Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma. Am J Respir Crit Care Med 2009, 180:203-210.
28. Suk J.S., Lai S.K., Boylan N.J., Dawson M.R., Boyle M.P., Hanes J. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine (Lond) 2011, 6:365-375.
29. Braeckmans K., Peeters L., Sanders N.N., De Smedt S.C., Demeester J. Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope. Biophys J 2003, 85:2240-2252.
30. Garbuzenko O.B., Saad M., Pozharov V.P., Reuhl K.R., Mainelis G., Minko T. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc Natl Acad Sci U S A 2010, 107:10737-10742.
31. Ballester M., Nembrini C., Dhar N., de Titta A., de Piano C., Pasquier M., et al. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine 2011, 29:6959-6966.
32. Nembrini C., Stano A., Dane K.Y., Ballester M., van der Vlies A.J., Marsland B.J., et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A 2011, 108:E989-E997.
33. Ensign L.M., Tang B.C., Wang Y.-Y., Tse T.A., Hoen T., Cone R., et al. Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med 2012, 4:138ra79.
34. World Health Organization Global health risks: mortality and burden of disease attributable to selected major risks 2009, World Health Organization, Geneva, Switzerland.
35. Cai L.H., Panyukov S., Rubinstein M. Mobility of nonsticky nanoparticles in polymer liquids. Macromolecules 2011, 44:7853-7863.
36. Wong I.Y., Gardel M.L., Reichman D.R., Weeks E.R., Valentine M.T., Bausch A.R., et al. Anomalous diffusion probes microstructure dynamics of entangled F-actin networks. Phys Rev Lett 2004, 92:178101.
37. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) 2011, 6:715-728.
38. de Gennes P.G. Conformations of polymers attached to an interface. Macromolecules 1980, 13:1069-1075.
39. Dickey B.F. Biochemistry. Walking on solid ground. Science 2012, 337:924-925.
40. Matthews L.W., Spector S., Lemm J., Potter J.L. Studies on pulmonary secretions. I. The over-all chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis 1963, 88:199-204.
41. Lai S.K., Wang Y.Y., Cone R., Wirtz D., Hanes J. Altering mucus rheology to " solidify" human mucus at the nanoscale. PLoS One 2009, 4:e4294.
42. Shin J.H., Gardel M.L., Mahadevan L., Matsudaira P., Weitz D.A. Relating microstructure to rheology of a bundled and cross-linked F-actin network in vitro. Proc Natl Acad Sci U S A 2004, 101:9636-9641.
43. Bernhard W., Haagsman H.P., Tschernig T., Poets C.F., Postle A.D., van Eijk M.E., et al. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. Am J Respir Cell Mol Biol 1997, 17:41-50.
44. Gehr P., Green F.H., Geiser M., Im Hof V., Lee M.M., Schurch S. Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J Aerosol Med 1996, 9:163-181.
45. Suk J.S., Boylan N.J., Trehan K., Tang B.C., Schneider C.S., Lin J.M., et al. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Mol Ther 2011, 19:1981-1989.